BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 12667701)

  • 1. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
    Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
    J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
    Trávnícek Z; Krystof V; Sipl M
    J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
    Trávnícek Z; Szucová L; Popa I
    J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines.
    Malon M; Trávnícek Z; Marek R; Strnad M
    J Inorg Biochem; 2005 Nov; 99(11):2127-38. PubMed ID: 16143400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity.
    Szucová L; Trávnícek Z; Zatloukal M; Popa I
    Bioorg Med Chem; 2006 Jan; 14(2):479-91. PubMed ID: 16198575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pd(II) and Pt(II) complexes with aromatic diamines: study of their interaction with DNA.
    Pérez-Cabré M; Cervantes G; Moreno V; Prieto MJ; Pérez JM; Font-Bardia M; Solans X
    J Inorg Biochem; 2004 Mar; 98(3):510-21. PubMed ID: 14987853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine.
    Novakova O; Liskova B; Vystrcilova J; Suchankova T; Vrana O; Starha P; Travnicek Z; Brabec V
    Eur J Med Chem; 2014 May; 78():54-64. PubMed ID: 24675180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and cytotoxicity of platinum(II)/palladium(II) complexes with 1,3-diaminopropane and 4-toluensulfonyl-L-amino acid dianion.
    Zhang J; Ma L; Lu H; Wang Y; Li S; Wang S; Zhou G
    Eur J Med Chem; 2012 Dec; 58():281-6. PubMed ID: 23137446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay.
    Faraglia G; Fregona D; Sitran S; Giovagnini L; Marzano C; Baccichetti F; Casellato U; Graziani R
    J Inorg Biochem; 2001 Jan; 83(1):31-40. PubMed ID: 11192697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of.
    Trávnícek Z; Malon M; Sindelál Z; Dolezal K; Rolcík J; Krystof V; Strnad M; Marek J
    J Inorg Biochem; 2001 Mar; 84(1-2):23-32. PubMed ID: 11330478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic, kinetic, and mechanistic study of a new mode of coordination of indole derivatives to platinum(II) and palladium(II) ions in complexes.
    Kaminskaia NV; Ullmann GM; Fulton DB; Kostic NM
    Inorg Chem; 2000 Oct; 39(22):5004-13. PubMed ID: 11233196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of new Pt(II) and Pd(II) complexes with 2-quinolinecarboxaldehyde selenosemicarbazone: cytotoxic activity evaluation of Cd(II), Zn(II), Ni(II), Pt(II) and Pd(II) complexes with heteroaromatic selenosemicarbazones.
    Gligorijević N; Todorović T; Radulović S; Sladić D; Filipović N; Godevac D; Jeremić D; Andelković K
    Eur J Med Chem; 2009 Apr; 44(4):1623-9. PubMed ID: 18789831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate and the X-ray crystal structure of the [Pd(asme)2] (asme=anionic form of the acetone Schiff base of S-methyldithiocarbazate) complex.
    Akbar Ali M; Mirza AH; Butcher RJ; Tarafder MT; Keat TB; Ali AM
    J Inorg Biochem; 2002 Nov; 92(3-4):141-8. PubMed ID: 12433421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.